ARKK Potential mean reversion pullback/correction

AMEX:ARKK   ARK Innovation ETF
ARKK price sitting a +3 standard deviations above identified linear regression mean with a potential RSI divergence identified signaling a possible pullback or correction to levels of support.

Linear regression analysis
  • ARKK's current bull trend beginning on MAR 18 2020 has been well identified
  • A linear regression trend pulled to current date gives a Pearson's R maxed at 0.97634... indicating a strong correlation
  • Current price is sitting at +3 standard deviations ( SD ) above linear regression mean

RSI Divergence
  • RSI divergence identified from DEC 23 2020 - JAN 15 2021 levels
  • As per my own RSI strategy, I overlay fibonacci retracement levels on my RSI indicator
  • Previous observations indicate that a price break below the 0.618 RSI level corresponds to a break of identified areas of support when found with a divergence of price action
  • Support at RSI range of 48-52 could correspond with a retest of some region of price action support

Cumulative analysis
As price action continues to make higher highs and RSI continue to make lower highs, I am looking for a pullback or potential correction to coincide with a potential mean reversion. Using RSI bearish divergence as a signal, I have a higher degree of confidence that this will occur.
Using fibonacci extension /retracement levels as well identified areas of support and resistance as they correspond to linear regression mean and SD areas, key areas of support appear to be at approximately $141.50, $138, and $131.

I will be watching price action over the next few days to watch for confirmation or rejection of this analysis as RSI is still in a bullish range and volume could certainly continue to push price higher and invalidate the currently observed possible divergence signal. A bullish move and breakout of ATH could see a move to $156.
Trade closed: target reached: Trade closed.
Support found at $138.
Closed short positions just before market close on JAN 27.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.